Callan Capital’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Callan Capital’s Portfolio SCHE Stock Details SCHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$7.66M	Sell	277,822 -3,243	-1%	-$88.8K	0.57%	32
2024 Q4	$7.48M	Buy	281,065 +22,867	+9%	+$646K	0.55%	34
2024 Q3	$7.53M	Sell	258,198 -17,678	-6%	-$478K	0.53%	35
2024 Q2	$7.33M	Sell	275,876 -15,689	-5%	-$409K	0.6%	30
2024 Q1	$7.36M	Buy	291,565 +6,229	+2%	+$153K	0.65%	29
2023 Q4	$7.07M	Buy	285,336 +69,848	+32%	+$1.68M	0.67%	31
2023 Q3	$5.16M	Buy	215,488 +980	+0.5%	+$24.3K	0.55%	37
2023 Q2	$5.28M	Buy	214,508 +3	+0%	+$73	0.58%	36
2023 Q1	$5.26M	Buy	214,505 +2,569	+1%	+$63.7K	0.61%	34
2022 Q4	$5.02M	Sell	211,936 -14,062	-6%	-$327K	0.62%	33
2022 Q3	$5.06M	Buy	225,998 +106,186	+89%	+$2.62M	0.82%	29
2022 Q2	$3.04M	Sell	119,812 -26,163	-18%	-$684K	0.47%	35
2022 Q1	$4.05M	Buy	145,975 +74,742	+105%	+$2.16M	0.56%	34
2021 Q4	$2.11M	Buy	71,233 +34,465	+94%	+$1.05M	0.31%	40
2021 Q3	$1.12M	Buy	36,768 +15,267	+71%	+$477K	0.19%	50
2021 Q2	$707K	Sell	21,501 -339	-2%	-$11K	0.12%	59
2021 Q1	$694K	Sell	21,840 -554	-2%	-$18K	0.13%	60
2020 Q4	$686K	Buy	22,394 +375	+2%	+$10.9K	0.14%	57
2020 Q3	$589K	Buy	22,019 +2,031	+10%	+$54.3K	0.13%	57
2020 Q2	$487K	Sell	19,988 -10,540	-35%	-$239K	0.12%	63
2020 Q1	$632K	Buy	30,528 +945	+3%	+$23.6K	0.19%	48
2019 Q4	$810K	Buy	29,583 +2,954	+11%	+$77.9K	0.22%	42
2019 Q3	$669K	Sell	26,629 -59	-0.2%	-$1.5K	0.19%	44
2019 Q2	$700K	Buy	26,688 +1,235	+5%	+$32K	0.23%	42
2019 Q1	$662K	Sell	25,453 -3,416	-12%	-$86.6K	0.22%	42
2018 Q4	$679K	Buy	28,869 +196	+0.7%	+$4.75K	0.25%	39
2018 Q3	$737K	Sell	28,673 -482	-2%	-$12.5K	0.24%	37
2018 Q2	$755K	Sell	29,155 -1,923	-6%	-$52.9K	0.26%	37
2018 Q1	$892K	Sell	31,078 -2,597	-8%	-$76.1K	0.29%	37
2017 Q4	$941K	Buy	33,675 +2,316	+7%	+$63.9K	0.33%	32
2017 Q3	$844K	Sell	31,359 -442	-1%	-$11.7K	0.31%	33
2017 Q2	$790K	Sell	31,801 -2,199	-6%	-$54K	0.3%	33
2017 Q1	$815K	Buy	34,000 +2,877	+9%	+$67K	0.33%	28
2016 Q4	$671K	Buy	31,123 +754	+2%	+$16.9K	0.3%	27
2016 Q3	$700K	Buy	30,369 +307	+1%	+$6.93K	0.29%	27
2016 Q2	$640K	Sell	30,062 -180	-0.6%	-$3.7K	0.26%	34
2016 Q1	$628K	Buy	30,242 +3,014	+11%	+$56.7K	0.26%	33
2015 Q4	$531K	Buy	+27,228	New	+$570K	0.21%	36

Other funds holding SCHE

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Financial Engines Advisors Santa Clara, California $56.3B AUM 17.83% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

SAG

SageView Advisory Group Newport Beach, California $3.05B AUM 18.61% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

RIM

Rakuten Investment Management Tokyo, Japan $34.6B AUM 29.24% 1-Year Est. Return

Callan Capital's SCHE Position: Q1 2025 in Review

Callan Capital reduced its Schwab Emerging Markets Equity ETF (SCHE) stake by 1.2% in Q1 2025, selling an estimated $88.8K and leaving 277,822 shares worth $7.66M. The position accounts for 0.57% of the portfolio, ranked #32.

Callan Capital first reported a position in SCHE in Q4 2015 and has held it in 38 quarters since. 761 funds tracked by Wall St. Rank hold SCHE as of Q1 2025.

Callan Capital held 277,822 shares of Schwab Emerging Markets Equity ETF worth $7.66M as of Q1 2025.
Callan Capital sold 3,243 Schwab Emerging Markets Equity ETF shares in Q1 2025, an estimated $88.8K.
Schwab Emerging Markets Equity ETF made up 0.57% of Callan Capital's portfolio in Q1 2025, its #32 holding.
Callan Capital first reported a position in Schwab Emerging Markets Equity ETF in Q4 2015 and has held it in 38 quarters since.
761 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.